Cargando…
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged in Chinese people in December 2019 and has currently spread worldwide causing the COVID-19 pandemic with more than 150,000 deaths. In order for a SARS-CoV like virus circulating in wild life for a very long time to infect...
Autores principales: | Devaux, Christian A., Rolain, Jean-Marc, Raoult, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201239/ https://www.ncbi.nlm.nih.gov/pubmed/32414646 http://dx.doi.org/10.1016/j.jmii.2020.04.015 |
Ejemplares similares
-
Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
por: Devaux, Christian A., et al.
Publicado: (2021) -
Endocrine Significance of SARS-CoV-2’s Reliance on ACE2
por: Lazartigues, Eric, et al.
Publicado: (2020) -
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020) -
What could explain the late emergence of COVID-19 in Africa?
por: Lalaoui, R., et al.
Publicado: (2020) -
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
por: Suryamohan, Kushal, et al.
Publicado: (2021)